Mark Christianson Neuroone Medical Technologies Corp (NMTC) insider trading activity

Mark Christianson is Business Development Director of NEUROONE MEDICAL TECHNOLOGIES Corp. Currently has a direct ownership of 294,079 shares of NMTC, which is worth approximately $276,434. The most recent transaction as insider was on Oct 31, 2024, when has been sold 90 shares (Common Stock) at a price of $0.97 per share, resulting in proceeds of $87. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 294K

0.18% 3M change

16.14% 12M change

Total Value Held $276,434

Mark Christianson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 31 2024	SELL Payment of exercise price or tax liability	$87 $0.97 p/Share	90 Reduced 0.03%	294,079 Common Stock
Sep 30 2024	SELL Payment of exercise price or tax liability	$339 $0.99 p/Share	343 Reduced 0.12%	294,169 Common Stock
Aug 31 2024	SELL Payment of exercise price or tax liability	$72 $0.8 p/Share	90 Reduced 0.03%	294,512 Common Stock
Jul 31 2024	SELL Payment of exercise price or tax liability	$67 $0.75 p/Share	90 Reduced 0.03%	294,602 Common Stock
Jun 30 2024	SELL Payment of exercise price or tax liability	$274 $0.8 p/Share	343 Reduced 0.12%	294,692 Common Stock
Jun 06 2024	SELL Open market or private sale	$1,926 $0.88 p/Share	2,189 Reduced 0.74%	295,035 Common Stock
Jun 05 2024	SELL Open market or private sale	$22,704 $0.88 p/Share	25,800 Reduced 7.99%	297,224 Common Stock
May 31 2024	SELL Payment of exercise price or tax liability	$83 $0.93 p/Share	90 Reduced 0.03%	323,024 Common Stock
Apr 30 2024	SELL Payment of exercise price or tax liability	$101 $1.13 p/Share	90 Reduced 0.03%	323,114 Common Stock
Apr 21 2024	SELL Payment of exercise price or tax liability	$2,334 $1.15 p/Share	2,030 Reduced 0.62%	323,204 Common Stock
Mar 31 2024	SELL Payment of exercise price or tax liability	$108 $1.2 p/Share	90 Reduced 0.03%	325,234 Common Stock
Feb 29 2024	SELL Payment of exercise price or tax liability	$108 $1.21 p/Share	90 Reduced 0.03%	325,324 Common Stock
Feb 18 2024	BUY Grant, award, or other acquisition	-	25,000 Added 7.13%	325,414 Common Stock
Jan 31 2024	SELL Payment of exercise price or tax liability	$112 $1.25 p/Share	90 Reduced 0.03%	300,414 Common Stock
Dec 31 2023	SELL Payment of exercise price or tax liability	$142 $1.58 p/Share	90 Reduced 0.03%	300,504 Common Stock
Dec 27 2023	SELL Open market or private sale	$45,909 $1.46 p/Share	31,445 Reduced 9.47%	300,594 Common Stock
Dec 26 2023	SELL Open market or private sale	$9,244 $1.35 p/Share	6,848 Reduced 2.02%	332,039 Common Stock
Dec 22 2023	SELL Open market or private sale	$2,520 $1.4 p/Share	1,800 Reduced 0.53%	338,887 Common Stock
Dec 21 2023	SELL Open market or private sale	$13,869 $1.4 p/Share	9,907 Reduced 2.83%	340,687 Common Stock
Nov 30 2023	SELL Payment of exercise price or tax liability	$130 $1.45 p/Share	90 Reduced 0.03%	350,594 Common Stock
Nov 02 2023	SELL Payment of exercise price or tax liability	$144 $1.61 p/Share	90 Reduced 0.03%	350,684 Common Stock
Oct 31 2023	SELL Payment of exercise price or tax liability	$81 $0.9 p/Share	90 Reduced 0.03%	350,774 Common Stock
Sep 30 2023	SELL Payment of exercise price or tax liability	$80 $0.89 p/Share	90 Reduced 0.03%	350,864 Common Stock
Aug 31 2023	SELL Payment of exercise price or tax liability	$76 $0.85 p/Share	90 Reduced 0.03%	350,954 Common Stock
Jul 31 2023	SELL Payment of exercise price or tax liability	$91 $1.02 p/Share	90 Reduced 0.03%	351,044 Common Stock

Mark Christianson

Business Development Director

Eden Prairie, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NMTC shares.

Notify only if

Value

Insider Trading

Get notified when an Neuroone Medical Technologies Corp insider buys or sells NMTC shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROONE MEDICAL TECHNOLOGIES Corp

Track Activities on NMTC

Account